Serum uromodulin (sUmod) represents a promising biomarker for acute kidney injury (AKI) in COVID-19 patients, as reported in a published collaborative study between EUROIMMUN, St Georg Hospital (Leipzig, Germany) and further institutes and clinics. AKI is a frequent complication in patients hospitalized with COVID-19 and is associated with an increased risk of fatal outcomes. Early […]

Diacylglycerol lipase alpha (DAGLA) has been identified as a novel autoantibody target in patients with rapid progressive cerebellar ataxia. The autoantibodies were characterised as part of a collaborative study between scientists at EUROIMMUN (Lübeck, Germany), the Hannover Medical School, (Hannover, Germany) and further institutes and clinics. The study was published in April 2024 the journal

Two new studies on SARS-CoV-2 vaccine immune responses suggest that the XBB.1.5-containing mRNA vaccines most likely increase protection against COVID-19 caused by currently circulating XBB variants and the emerging BA.2.86 variant in healthy persons and in patients on haemodialysis. The studies build on collaborative work between the Hannover Medical School, Germany and EUROIMMUN and were

Dried blood spots (DBS) collected from the fingertip yield reliable results in analysis of anti-SARS-CoV-2 antibodies, even after prolonged storage of DBS eluates for 6 to 8 hours. This was demonstrated in a recently published study from MVZ Labor Krone GbR in Bad Salzuflen, Germany, in collaboration with EUROIMMUN and further institutions. DBS are an

A recent study has demonstrated substantial differences in SARS-CoV-2 immunity after Omicron infection in triple-COVID-19-vaccinated and antigen-naïve individuals, which may influence cross-protection against future variants. The study was performed as part of a collaboration between the Hannover Medical School, Germany and EUROIMMUN. Omicron variants are B-cell immune escape variants of SARS-CoV-2 that elude the defence